Finland· FI-REL-REL64163
Jascayd
A nerandomilast product containing nerandomilast, registered in Finland by Boehringer Ingelheim International GmbH. The same ATC class is registered in 9 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Nerandomilast is registered in 9 of 19 countries.
Countries holding a registration under ATC L04AA61 (nerandomilast), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 5 of them publish a price we can compare per daily dose
Nerandomilast · ATC L04AA61
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Japan
- Netherlands
- Polandprice
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Nerandomilast
- Manufacturer
- Boehringer Ingelheim International GmbH
- Country
- Finland (FI)
- ATC code
- L04AA61
- ATC class
- Nerandomilast
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nerandomilast in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaJASCAYDBoehringer Ingelheim International GmbH, Ingelheim am Rhein
- United StatesJASCAYDBoehringer Ingelheim Pharmaceuticals, Inc.
- IrelandJascayd 9 mg film-coated tabletsBoehringer Ingelheim International GmbH
- BelgiumJascayd 9 mgBoehringer Ingelheim International
- PolandJascaydBoehringer Ingelheim International GmbH
- SwedenJascayd 9 mg Filmdragerad tablettBoehringer Ingelheim International GmbH
- NetherlandsJascayd 9 mg filmomhulde tablettenBoehringer Ingelheim International GmbH
- SpainJASCAYD 9 MG COMPRIMIDOS RECUBIERTOS CON PELICULABoehringer Ingelheim International Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Jascayd
- Liechtenstein · Jascayd
- Norway · Jascayd
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4e2f6530-e1af-45aa-94d7-fe9b8fef7e6e GET /v1/drugs/4e2f6530-e1af-45aa-94d7-fe9b8fef7e6e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "tabletti, kalvopäällysteinen",
"route": "Suun kautta",
"ddd_unit": null,
"strength": "9 mg",
"atc_label": "nerandomilasti",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/26/2040/001-005",
"fimea_rel_id": "REL64163",
"authorised_at": "2026-07-15"
}See everything about nerandomilast.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.